Recent announcements of Anthropic’s Bay Area wet lab for real-world biology experiments with Claude models, paired with its new Life Sciences Verification Program granting verified researchers less-restricted access, have sharpened trader focus on potential capability leaks. These moves coincide with disclosures that Claude now leads 26% of the company’s internal R&D and ongoing reports of large-scale distillation attacks by foreign labs attempting to exfiltrate reasoning capabilities. Safety partnerships, such as the $2 billion embedded evaluation effort with Accenture, underscore internal risk management but also highlight the expanding surface for unauthorized access or misuse. Upcoming catalysts include further model releases and regulatory scrutiny around AI-biology intersections that could shift implied probabilities on leak timelines.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日新規
$21,294 Vol.
2026/12/31
2026年12月31日
4%
2027年6月30日
11%
$21,294 Vol.
2026年12月31日
$14,632 Vol.
4%
2027年6月30日
$6,662 Vol.
11%
This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.Recent announcements of Anthropic’s Bay Area wet lab for real-world biology experiments with Claude models, paired with its new Life Sciences Verification Program granting verified researchers less-restricted access, have sharpened trader focus on potential capability leaks. These moves coincide with disclosures that Claude now leads 26% of the company’s internal R&D and ongoing reports of large-scale distillation attacks by foreign labs attempting to exfiltrate reasoning capabilities. Safety partnerships, such as the $2 billion embedded evaluation effort with Accenture, underscore internal risk management but also highlight the expanding surface for unauthorized access or misuse. Upcoming catalysts include further model releases and regulatory scrutiny around AI-biology intersections that could shift implied probabilities on leak timelines.
This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
マーケット開始日： Sep 18, 2026, 8:27 PM ET
音量
$21,294終了日
2027/07/01マーケット開始日
Sep 18, 2026, 8:27 PM ETリゾルバー
0x65070BE91...This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.Recent announcements of Anthropic’s Bay Area wet lab for real-world biology experiments with Claude models, paired with its new Life Sciences Verification Program granting verified researchers less-restricted access, have sharpened trader focus on potential capability leaks. These moves coincide with disclosures that Claude now leads 26% of the company’s internal R&D and ongoing reports of large-scale distillation attacks by foreign labs attempting to exfiltrate reasoning capabilities. Safety partnerships, such as the $2 billion embedded evaluation effort with Accenture, underscore internal risk management but also highlight the expanding surface for unauthorized access or misuse. Upcoming catalysts include further model releases and regulatory scrutiny around AI-biology intersections that could shift implied probabilities on leak timelines.
This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
音量
$21,294終了日
2027/07/01マーケット開始日
Sep 18, 2026, 8:27 PM ETリゾルバー
0x65070BE91...Recent announcements of Anthropic’s Bay Area wet lab for real-world biology experiments with Claude models, paired with its new Life Sciences Verification Program granting verified researchers less-restricted access, have sharpened trader focus on potential capability leaks. These moves coincide with disclosures that Claude now leads 26% of the company’s internal R&D and ongoing reports of large-scale distillation attacks by foreign labs attempting to exfiltrate reasoning capabilities. Safety partnerships, such as the $2 billion embedded evaluation effort with Accenture, underscore internal risk management but also highlight the expanding surface for unauthorized access or misuse. Upcoming catalysts include further model releases and regulatory scrutiny around AI-biology intersections that could shift implied probabilities on leak timelines.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問